Effects of imidazoline I 2 receptor agonists and morphine on schedule-controlled responding in rats

Pharmacology Biochemistry and Behavior

Volumn 101, Issue 3, 2012, Pages 354-359

  An, Xiao Fei ^a,b   Zhang, Yanan ^c   Winter, Jerrold C ^a   Li, Jun Xu ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c RTI INTERNATIONAL   (United States)

Author keywords

Dose addition analysis; Imidazoline I 2 receptor; Morphine; Rats; Schedule controlled responding

Indexed keywords

2 (2 BENZOFURANYL) 2 IMIDAZOLINE HYDROCHLORIDE; 2 (2 IMIDAZOLIN 2 YL)QUINOLINE; IMIDAZOLINE DERIVATIVE; MORPHINE SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; BENZOFURANS; CONDITIONING, OPERANT; DRUG INTERACTIONS; IMIDAZOLES; IMIDAZOLINE RECEPTORS; MALE; MORPHINE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; REINFORCEMENT SCHEDULE;

RATTUS;

EID: 84862784916     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.01.024     Document Type: Article

References (35)

1. Andrieu G, Roth B, Ousmane L, Castaner M, Petillot P, Vallet B, et al. The efficacy of intrathecal morphine with or without clonidine for postoperative analgesia after radical prostatectomy. Anesth Analg 2009;108:1954-7.
2. Annemans L. Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent pain. Clin Drug Investig 2011;31:73-86.
3. Banks ML, Folk JE, Rice KC, Negus SS. Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics. Pharmacol Biochem Behav 2010;97:205-12.
4. Boronat MA, Olmos G, Garcia-Sevilla JA. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands. Br J Pharmacol 1998;125:175-85. (Pubitemid 28418770)
5. Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 1984;230:232-6. (Pubitemid 14097683)
6. Brown CM, MacKinnon AC, RedfernWS, Williams A, Linton C, StewartM, et al. RS-45041- 190: a selective, high-affinity ligand for I2 imidazoline receptors. Br J Pharmacol 1995;116:1737-44.
7. Carney JM, Rosecrans JA. Effects of morphine and two enzyme resistant enkephalins on schedule-controlled responding in the rat. Pharmacol Biochem Behav 1978;8:185-9. (Pubitemid 8348163)
8. Dews PB. Studies on behavior. I. Differential sensitivity to pentobarbital of pecking performance in pigeons depending on the schedule of reward. J Pharmacol Exp Ther 1955;113:393-401.
9. Eglen RM, Hudson AL, Kendall DA, Nutt DJ, Morgan NG,Wilson VG, et al. 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. Trends Pharmacol Sci 1998;19:381-90. (Pubitemid 28458836)
10. Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, et al. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci USA 2000;97:10584-9.
11. Ferrari F, Fiorentino S, Mennuni L, Garofalo P, Letari O, Mandelli S, et al. Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain. J Pain Res 2011;4:111-25.
12. Finger BC, Dinan TG, Cryan JF. Progressive ratio responding in an obese mouse model: effects of fenfluramine. Neuropharmacology 2010;59:619-26.
13. Garcia-Sevilla JA, Escriba PV, Guimon J. Imidazoline receptors and human brain disorders. Ann N Y Acad Sci 1999;881:392-409. (Pubitemid 29349535)
14. Hudson AL, Chapleo CB, Lewis JW, Husbands S, Grivas K, Mallard NJ, et al. Identification of ligands selective for central I2-imidazoline binding sites. Neurochem Int 1997;30:47-53. (Pubitemid 27032543)
15. Hudson AL, Gough R, Tyacke R, Lione L, LaliesM, Lewis J, et al. Novel selective compounds for the investigation of imidazoline receptors. Ann N Y Acad Sci 1999;881:81-91. (Pubitemid 29349492)
16. Ishihara M, Togo H. Direct oxidative conversion of aldehydes and alcohols to 2-imidazolines and 2-oxazolines using molecular iodine. Tetrahedron 2007;63:1474-80. (Pubitemid 44969407)
17. Kelleher RT, Morse WH. Determinants of the specificity of behavioral effects of drugs. Ergeb Physiol 1968;60:1-56.
18. Li JX, Zhang Y. Imidazoline I2 receptors: target for new analgesics? Eur J Pharmacol 2011;658:49-56.
19. Li X, Li JX, France CP. Interactions between morphine, scopolamine and nicotine: schedule-controlled responding in rats. Pharmacol Biochem Behav 2010;96:91-5.
20. Li JX, Crocker C, Koek W, Rice KC, France CP. Effects of serotonin (5-HT)1A and 5-HT2A receptor agonists on schedule-controlled responding in rats: drug combination studies. Psychopharmacology (Berl) 2011a;213:489-97.
21. Li JX, Koek W, Rice KC, France CP. Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys. Neuropsychopharmacology 2011b;36:940-9.
22. Li JX, Zhang Y, Winter JC.Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I receptor ligands. Eur J Pharmacol 2011c;669:59-65.
23. Nevin JA, Grace RC. Behavioral momentum and the law of effect. Behav Brain Sci 2000;23:73-90. discussion -130.
24. Nutt DJ, French N, Handley S, Hudson A, Husbands S, Jackson H, et al. Functional studies of specific imidazoline-2 receptor ligands. Ann N Y Acad Sci 1995;763:125-39.
25. Pinkston JW, Ginsburg BC, Lamb RJ. Examination of reinforcement magnitude on the pharmacological disruption of fixed-ratio performance. Exp Clin Psychopharmacol 2009;17:237-46.
26. Polidori C, Gentili F, Pigini M, Quaglia W, Panocka I, Massi M. Hyperphagic effect of novel compounds with high affinity for imidazoline I(2) binding sites. Eur J Pharmacol 2000;392:41-9. (Pubitemid 30169031)
27. Raffa RB, Pergolizzi Jr JV, Tallarida RJ. The determination and application of fixed-dose analgesic combinations for treating multimodal pain. J Pain 2010;11:701-9.
28. Ruiz-Durantez E, Torrecilla M, Pineda J, Ugedo L. Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neurons. Br J Pharmacol 2003;138:494-500. (Pubitemid 36269489)
29. Sampson C, Zhang Y, Del Bello F, Li JX. Effects of imidazoline I2 receptor ligands on acute nociception in rats. Neuroreport 2012;23:73-7.
30. Sanchez-Blazquez P, Boronat MA, Olmos G, Garcia-Sevilla JA, Garzon J. Activation of I(2)- imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors. Br J Pharmacol 2000;130:146-52. (Pubitemid 30248438)
31. Smith HS. Combination opioid analgesics. Pain Physician 2008;11:201-14. (Pubitemid 351546231)
32. Solinas M, Goldberg SR. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology 2005;30:2035-45. (Pubitemid 43093503)
33. Stevenson GW, Folk JE, Rice KC, Negus SS. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug selfadministration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5- dimethyl-1-piperazinyl)-3-meth oxybenzyl]- N,N-diethylbenzamide] and heroin. J Pharmacol Exp Ther 2005;314:221-31. (Pubitemid 41058259)
34. Thorn DA, Zhang Y, Peng BW, Winter JC, Li JX. Effects of imidazoline I(2) receptor ligands on morphine- and tramadol-induced antinociception in rats. Eur J Pharmacol 2011;670:435-40.
35. Wu N, Su RB, Li J. Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence. Cell Mol Neurobiol 2008;28:629-41. (Pubitemid 351905063)